<DOC>
	<DOCNO>NCT01333735</DOCNO>
	<brief_summary>The aim study investigate impact adjuvant chemotherapy cognitive function patient age 65 suffer breast cancer colon .</brief_summary>
	<brief_title>Impact Cognitive Function Quality Life Adjuvant Chemotherapy Patients Aged Over 65 Years : Application Breast Cancer Colon</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Inclusion Criteria patient chemotherapy : Patient ( e ) age 65 year Non metastatic breast cancer Adjuvant chemotherapy Breast cancer : FEC , include Docetaxel Protocols No major cognitive impairment Lack personality disorder psychiatric disorder evolutionary Having sign informed consent study participation Inclusion Criteria patient without chemotherapy ( control group ) : Patient ( e ) age 65 year Breast cancer Patients receive adjuvant chemotherapy No major cognitive impairment Lack personality disorder psychiatric disorder evolutionary Having sign informed consent study participation Matching age , sex , cultural level tumor location Exclusion Criteria patient chemotherapy : Metastatic Cancer primitive breast Patients 65 year Patients adjuvant chemotherapy associate targeted therapy Patients receive cancer treatment ( chemotherapy radiotherapy brain ) disorder high function exist administration chemotherapy Pathology psychiatric evolutionary Refusal participation Patients unable meet cognitive test Drug use Heavy drinking</criteria>
	<gender>Female</gender>
	<minimum_age>66 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>cognitive function</keyword>
	<keyword>quality life</keyword>
	<keyword>breast cancer</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>age patient</keyword>
</DOC>